. 2014 Jul 25;5(21):10460–10472. doi: 10.18632/oncotarget.2260

Table 1. IC₅₀ for Viability.

Cells	Everolimus (μM)			BEZ235 (μM)			BGT226 (μM)
Time (h)	24	48	72	24	48	72	24	48	72
LK63	10	10	10	40	3.0	4.0	0.60	0.43	0.33
NALM6	10	10	10	30	15	1.0	1.00	0.83	0.20
REH	11	11	11	>128	46	43	0.60	0.50	0.50
2032	13			73			0.50
2070	12			110			0.90
1786	12			46			1.3

Table 1. IC50 for Viability.